(Press-News.org) Thioperamide, a selective histamine H3 receptor antagonist, can increase histamine content in the brain and improve brain edema in adult hypoxic rats. Brain edema is precisely considered as the important pathological change of neonatal hypoxic-ischemic encephalopathy. As a study reported in the Neural Regeneration Research (Vol. 8, No. 19, 2013), thioperamide was used to increase histamine content in the brain, and then the mechanism of action of thioperamide during brain edema in a rat model of neonatal hypoxic-ischemic encephalopathy was examined. Results showed that thioperamide significantly decreased brain water content and malondialdehyde levels, while significantly increased histamine levels and su-peroxide dismutase activity in the hippocampus. This evidence demonstrates that thioperamide could prevent oxidative damage and attenuate brain edema following neonatal hypoxic-ischemic encephalopathy. The researchers further found that the H1 receptor antagonist, pyrilamine, reversed the effects of thioperamide; however, the H2 receptor antagonist, cimetidine, had no significant influence on the effects of thioperamide. The researchers suggest that thioperamide can increase brain histamine content and attenuate brain edema and oxidative damage by acting in combination with postsynaptic H1 receptors in a rat model of neonatal hypoxic-ischemic encephalopathy.
INFORMATION:
Article: " Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors " by Feiyong Jia, Lin Du, Yunpeng Hao, Shicheng Liu, Ning Li, Huiyi Jiang (Division of Pediatric Neurorehabilitation, Department of Pediatrics, Second Part of First Hospital of Jilin University, Changchun 130031, Jilin Province, China)
Jia FY, Du L, Hao YP, Liu SC, Li N, Jiang HY. Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors. Neural Regen Res. 2013;8(19):1814-1822.
Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/
Full text: http://www.sjzsyj.org:8080/Jweb_sjzs/CN/article/downloadArticleFile.do?attachType=PDF&id=652
Mechanism underlying the ability of H3 receptor antagonist to treat brain edema
2013-08-12
ELSE PRESS RELEASES FROM THIS DATE:
Limb-girdle muscular dystrophy subtypes in the population of Northeast China
2013-08-12
The most common limb-girdle muscular dystrophy subtype in Italy, Spain, Turkey, Russia, Brazil and Australia is calpainopathy (limb-girdle muscular dystrophy type 2A), while dystroglycanopathy (limb-girdle muscular dystrophy type 2I) is the commonest form in Norway, Denmark and northern England. In India, sarcoglycanopthies (limb-girdle muscular dystrophy type 2C-2F) are the most preva-lent, while dysferlinopathies are the most frequent type in USA and Japan. A rigorous comparison of the morphological features of biopsy specimens between limb-girdle muscular dystrophy type ...
X-linked MeCP2 is first reported to be a new target for treating Parkinson's disease
2013-08-12
X-linked methyl-CpG binding protein 2 plays important role in the regulation of neuronal development, proliferation and maturation, and synaptic regeneration and apoptosis. Overexpression of X-linked methyl-CpG binding protein 2 in SH-SY5Y cells can reduce cell apoptosis induced by 6-hydroxydopamine and increased tyrosine hydroxylase expression. But the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson's disease remains unknown. Prof. Xianhou Yuan and team from Zhongnan Hospital of Wuhan University used 6-hydroxydopamine-induced human ...
Solutions for improving first aid in cardiorespiratory arrests
2013-08-12
An algorithm capable of diagnosing heart rhythm with just 3 seconds' worth of signal, and the demonstration that it is possible to come up with the diagnosis without stopping cardiac massage, constitute the types of solutions and proposals being developed by researchers in the Signal and Communications Group of the Faculty of Engineering in Bilbao (UPV/EHU-University of the Basque Country).
"We don't save lives, we just do research," as Jesús Ruiz, leader of the Signal and Communications Group, makes it clear. "But what has been confirmed is that it is cardiac massage ...
Estrogen enhancers tied to aggressive breast cancer
2013-08-12
SAN ANTONIO -- Adding to the picture of what prompts breast cancers to form, researchers from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center San Antonio today announced that "distant estrogen response elements" (DEREs) can act independently of oncogenes to spur tumor development.
DEREs appear to be depots or hubs that remotely and simultaneously control multiple target genes in response to estrogen stimulation, said Pei-Yin Hsu, Ph.D., lead author of the paper in Cancer Cell. As such, they are prime targets for the study of ...
Use of simple rule in children's ankle injuries reduces use of radiography by 22 percent
2013-08-12
Radiography is widely used in diagnosing ankle injuries, with 85%–95% in pediatric injuries, although only 12% of these show fractures.
"Radiography is unnecessary for most children's ankle injuries, and these high rates of radiography needlessly expose children to radiation and are a questionable use of resources," writes Dr. Kathy Boutis, a pediatric emergency department physician at the Hospital for Sick Children (SickKids) and the University of Toronto, with coauthors.
The Low Risk Ankle Rule is highly accurate at identifying fractures and can potentially reduce ...
'Dark-horse' molecule is a potential new anti-cancer target
2013-08-12
Contact: Vanessa Solomon
solomon@wehi.edu.au
61-393-452-971
Walter and Eliza Hall Institute
Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
'Dark-horse' molecule is a potential new anti-cancer target
Australian researchers have identified a molecule called interleukin-11 as a potential new target for anti-cancer therapies.
Until now, the importance of interleukin-11 in cancer development has been underestimated, but researchers have recently identified this molecule as a 'dark horse' for the development of cancer. ...
Aggressive breast cancers may be sensitive to drugs clogging their waste disposal
2013-08-12
Boston, Mass., August 12, 2013 – In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.
These cancers, which lack the three major therapeutic markers for breast cancer—the estrogen, progesterone and HER2 receptors—are very aggressive and difficult to treat. They mostly affect younger women ...
Young or old, song sparrows experience climate change differently from each other
2013-08-12
What's good for adults is not always best for the young, and vice versa. At least that is the case with song sparrows and how they experience the effects of climate change, according to two recent studies by scientists at the University of California, Davis, and Point Blue Conservation Science.
Both studies show the importance of considering the various stages and ages of individuals in a species -- from babies to juveniles to adults -- to best predict not only how climate change could affect a species as a whole, but also why.
"To learn how climate change is expected ...
Singapore scientists unravel cancers linked to herbal remedies
2013-08-12
Singapore, 12 August 2013 – A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming. Using advanced DNA sequencing technologies, the team, led by Professors Teh Bin Tean, See-Tong Pang, Patrick Tan and Steve Rozen discovered that AA is the most potent carcinogen ...
Largest study of epilepsy patients ever conducted reveals new and surprising genetic risk factors
2013-08-12
NEW YORK, August 11 – Neurologists and epilepsy researchers from NYU Langone Medical Center were among scientists who have 329 random genetic mutations associated with two of the most severe forms of epilepsy, according to a paper published today in Nature. Though well-known that many forms of epilepsy are strongly influenced by genetics, there has been relatively little progress in identifying the genetic differences that contribute to most forms of epilepsy. This study sheds light on why some with an elevated risk for epilepsy never get the disease and why certain medications ...